BR112020007557A2 - inibidores de aminoimidazopiridazinas como inibidores de cinase - Google Patents
inibidores de aminoimidazopiridazinas como inibidores de cinaseInfo
- Publication number
- BR112020007557A2 BR112020007557A2 BR112020007557-4A BR112020007557A BR112020007557A2 BR 112020007557 A2 BR112020007557 A2 BR 112020007557A2 BR 112020007557 A BR112020007557 A BR 112020007557A BR 112020007557 A2 BR112020007557 A2 BR 112020007557A2
- Authority
- BR
- Brazil
- Prior art keywords
- alkyl
- mmol
- pyridazin
- alkoxy
- cycloalkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762578607P | 2017-10-30 | 2017-10-30 | |
| US62/578,607 | 2017-10-30 | ||
| US201862626853P | 2018-02-06 | 2018-02-06 | |
| US62/626,853 | 2018-02-06 | ||
| PCT/US2018/057968 WO2019089442A1 (en) | 2017-10-30 | 2018-10-29 | Aminoimidazopyridines as kinase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112020007557A2 true BR112020007557A2 (pt) | 2020-09-24 |
Family
ID=64332173
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112020007557-4A BR112020007557A2 (pt) | 2017-10-30 | 2018-10-29 | inibidores de aminoimidazopiridazinas como inibidores de cinase |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US11440913B2 (enExample) |
| EP (1) | EP3704118B1 (enExample) |
| JP (1) | JP7228586B2 (enExample) |
| KR (1) | KR102662197B1 (enExample) |
| CN (1) | CN111566103B (enExample) |
| AU (1) | AU2018361249B2 (enExample) |
| BR (1) | BR112020007557A2 (enExample) |
| CA (1) | CA3080402A1 (enExample) |
| CY (1) | CY1124984T1 (enExample) |
| DK (1) | DK3704118T3 (enExample) |
| ES (1) | ES2905948T3 (enExample) |
| HR (1) | HRP20220297T1 (enExample) |
| HU (1) | HUE058292T2 (enExample) |
| IL (1) | IL274207B2 (enExample) |
| LT (1) | LT3704118T (enExample) |
| MX (1) | MX2020003706A (enExample) |
| PL (1) | PL3704118T3 (enExample) |
| PT (1) | PT3704118T (enExample) |
| RS (1) | RS62974B1 (enExample) |
| SG (1) | SG11202003824PA (enExample) |
| SI (1) | SI3704118T1 (enExample) |
| SM (1) | SMT202200087T1 (enExample) |
| WO (1) | WO2019089442A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2902676T3 (es) | 2017-02-13 | 2022-03-29 | Bristol Myers Squibb Co | Aminotriazolopiridinas como inhibidores de cinasa |
| CA3088548A1 (en) | 2018-01-26 | 2019-08-01 | Bristol-Myers Squibb Company | Aminopyrrolotriazines as kinase inhibitors |
| BR112021004310A2 (pt) | 2018-09-13 | 2021-05-25 | Bristol-Myers Squibb Company | indazolcarboxamidas como inibidores de cinase |
| BR112021004385A2 (pt) | 2018-09-13 | 2021-07-20 | Bristol-Myers Squibb Company | 1h-indazol carboxamidas como inibidores de proteína quinase de interação com o receptor 1 (ripk1) |
| GB201905721D0 (en) | 2019-04-24 | 2019-06-05 | Univ Dundee | Compounds |
| US12275721B2 (en) | 2019-10-03 | 2025-04-15 | Bristol-Myers Squibb Company | Indazole carboxamides as kinase inhibitors |
| WO2021168521A1 (en) * | 2020-02-27 | 2021-09-02 | Anaxis Pharma Pty Ltd | Inhibitors of necroptosis |
| CN114262322A (zh) * | 2020-09-16 | 2022-04-01 | 中国科学院上海有机化学研究所 | 一类细胞程序性坏死抑制剂及其制备方法和用途 |
| WO2022081522A1 (en) | 2020-10-13 | 2022-04-21 | The Johns Hopkins University | SUBSTITUTED 4-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)THIOPHENE-2-CARBOXAMIDE DERIVATIVES AND USE THEREOF |
| AR123793A1 (es) * | 2020-10-19 | 2023-01-11 | Bristol Myers Squibb Co | Compuestos de triazolopiridinilo como inhibidores de quinasas |
| CN120530112A (zh) * | 2022-12-30 | 2025-08-22 | 广州市联瑞制药有限公司 | 双环类化合物及其制备方法和应用 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20070978A1 (es) | 2006-02-14 | 2007-11-15 | Novartis Ag | COMPUESTOS HETEROCICLICOS COMO INHIBIDORES DE FOSFATIDILINOSITOL 3-QUINASAS (PI3Ks) |
| US7820665B2 (en) * | 2007-12-19 | 2010-10-26 | Amgen Inc. | Imidazopyridazine inhibitors of PI3 kinase for cancer treatment |
| CA2750517A1 (en) * | 2009-02-04 | 2010-08-12 | Vitae Pharmaceuticals, Inc. | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| BR112014030147B1 (pt) | 2012-06-22 | 2019-10-15 | Sumitomo Chemical Company, Limited | Compostos heterocíclicos fundidos, composição e método para controlar pestes |
| EP2897949B1 (en) | 2012-09-18 | 2018-01-10 | Bristol-Myers Squibb Company | Iap antagonists |
| ES2749467T3 (es) | 2012-11-20 | 2020-03-20 | Biogen Ma Inc | Agentes moduladores de S1p y/o ATX |
| EP2970266B1 (en) | 2013-03-15 | 2018-01-31 | Epizyme, Inc. | 1-phenoxy-3-(alkylamino)-propan-2-ol derivatives as carm1 inhibitors and uses thereof |
| CN105246891A (zh) | 2013-06-10 | 2016-01-13 | 拜耳制药股份公司 | 用于治疗癌症的新化合物 |
| WO2016027253A1 (en) | 2014-08-21 | 2016-02-25 | Glaxosmithkline Intellectual Property Development Limited | Heterocyclic amides as rip1 kinase inhibitors as medicaments |
| WO2017192930A1 (en) | 2016-05-05 | 2017-11-09 | Lysosomal Therapeutics Inc. | SUBSTITUTED IMIDAZO[1,2-b]PYRIDAZINES, SUBSTITUTED IMIDAZO[1,5-b]PYRIDAZINES, RELATED COMPOUNDS, AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS |
| WO2018017435A1 (en) | 2016-07-22 | 2018-01-25 | Accro Bioscience Inc. | Heteroaryl compounds as inhibitors of necrosis, composition and application thereof |
| ES2902676T3 (es) | 2017-02-13 | 2022-03-29 | Bristol Myers Squibb Co | Aminotriazolopiridinas como inhibidores de cinasa |
| CA3088548A1 (en) | 2018-01-26 | 2019-08-01 | Bristol-Myers Squibb Company | Aminopyrrolotriazines as kinase inhibitors |
| BR112021004385A2 (pt) | 2018-09-13 | 2021-07-20 | Bristol-Myers Squibb Company | 1h-indazol carboxamidas como inibidores de proteína quinase de interação com o receptor 1 (ripk1) |
| BR112021004310A2 (pt) | 2018-09-13 | 2021-05-25 | Bristol-Myers Squibb Company | indazolcarboxamidas como inibidores de cinase |
| EP3877371A4 (en) * | 2018-11-07 | 2022-07-27 | Dana-Farber Cancer Institute, Inc. | IMIDAZOPYRIDINE DERIVATIVES AND AZA-IMIDAZOPYRIDINE DERIVATIVES USED AS JANUS KINASE 2 INHIBITORS AND ASSOCIATED USES |
-
2018
- 2018-10-29 MX MX2020003706A patent/MX2020003706A/es unknown
- 2018-10-29 EP EP18804177.6A patent/EP3704118B1/en active Active
- 2018-10-29 SM SM20220087T patent/SMT202200087T1/it unknown
- 2018-10-29 SG SG11202003824PA patent/SG11202003824PA/en unknown
- 2018-10-29 PL PL18804177T patent/PL3704118T3/pl unknown
- 2018-10-29 US US16/758,892 patent/US11440913B2/en active Active
- 2018-10-29 JP JP2020524156A patent/JP7228586B2/ja active Active
- 2018-10-29 ES ES18804177T patent/ES2905948T3/es active Active
- 2018-10-29 LT LTEPPCT/US2018/057968T patent/LT3704118T/lt unknown
- 2018-10-29 KR KR1020207015195A patent/KR102662197B1/ko active Active
- 2018-10-29 DK DK18804177.6T patent/DK3704118T3/da active
- 2018-10-29 AU AU2018361249A patent/AU2018361249B2/en not_active Ceased
- 2018-10-29 RS RS20220215A patent/RS62974B1/sr unknown
- 2018-10-29 HR HRP20220297TT patent/HRP20220297T1/hr unknown
- 2018-10-29 SI SI201830556T patent/SI3704118T1/sl unknown
- 2018-10-29 PT PT188041776T patent/PT3704118T/pt unknown
- 2018-10-29 CA CA3080402A patent/CA3080402A1/en active Pending
- 2018-10-29 WO PCT/US2018/057968 patent/WO2019089442A1/en not_active Ceased
- 2018-10-29 CN CN201880084047.7A patent/CN111566103B/zh active Active
- 2018-10-29 BR BR112020007557-4A patent/BR112020007557A2/pt not_active IP Right Cessation
- 2018-10-29 HU HUE18804177A patent/HUE058292T2/hu unknown
-
2020
- 2020-04-24 IL IL274207A patent/IL274207B2/en unknown
-
2022
- 2022-03-08 CY CY20221100117T patent/CY1124984T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL274207B2 (en) | 2023-04-01 |
| JP2021501179A (ja) | 2021-01-14 |
| SMT202200087T1 (it) | 2022-03-21 |
| PL3704118T3 (pl) | 2022-04-04 |
| HRP20220297T1 (hr) | 2022-05-13 |
| US20200277296A1 (en) | 2020-09-03 |
| AU2018361249A1 (en) | 2020-06-11 |
| RS62974B1 (sr) | 2022-03-31 |
| KR102662197B1 (ko) | 2024-04-29 |
| CN111566103B (zh) | 2023-06-23 |
| MX2020003706A (es) | 2020-07-22 |
| EP3704118A1 (en) | 2020-09-09 |
| SI3704118T1 (sl) | 2022-04-29 |
| LT3704118T (lt) | 2022-02-25 |
| CN111566103A (zh) | 2020-08-21 |
| AU2018361249B2 (en) | 2022-08-25 |
| WO2019089442A8 (en) | 2019-06-27 |
| JP7228586B2 (ja) | 2023-02-24 |
| HUE058292T2 (hu) | 2022-07-28 |
| KR20200078591A (ko) | 2020-07-01 |
| EP3704118B1 (en) | 2022-01-12 |
| CY1124984T1 (el) | 2023-01-05 |
| SG11202003824PA (en) | 2020-05-28 |
| IL274207B (en) | 2022-12-01 |
| IL274207A (en) | 2020-06-30 |
| DK3704118T3 (da) | 2022-03-14 |
| ES2905948T3 (es) | 2022-04-12 |
| WO2019089442A1 (en) | 2019-05-09 |
| CA3080402A1 (en) | 2019-05-09 |
| PT3704118T (pt) | 2022-02-14 |
| US11440913B2 (en) | 2022-09-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112020007557A2 (pt) | inibidores de aminoimidazopiridazinas como inibidores de cinase | |
| CN104684915B (zh) | 新型双环衍生物 | |
| TW200539858A (en) | Amido compounds and their use as pharmaceuticals | |
| JP2023500611A (ja) | Ｈｅｌｉｏｓの低分子分解誘導剤および使用方法 | |
| ES2656198T3 (es) | Derivados del octahidro-ciclobuta[1,2-c;3,4-c']dipirrol como inhibidores de la autotaxina | |
| PT1720859E (pt) | Antagonistas do receptor de quimiocina | |
| CA2922933A1 (en) | 2,8-diazaspiro[4.5]decane and 3,9-dispiro[5.5]undecane derivates and pharmaceutical compositions thereof useful as tryptophan hydroxylase inhibitors | |
| WO2016065980A1 (zh) | 异吲哚啉衍生物、其中间体、制备方法、药物组合物及应用 | |
| TW201217359A (en) | Novel compounds and compositions for the inhibition of NAMPT | |
| CA3047580A1 (en) | Compounds and methods for cdk8 modulation and indications therefor | |
| JP6458028B2 (ja) | インドール及びピロールの新規な誘導体、その製造方法及びそれを含む医薬組成物 | |
| BR112013005889A2 (pt) | triazinaoxadiazóis, composição farmacêutica que os compreende e uso dos mesmos | |
| KR20150132556A (ko) | 과다증식성 장애의 치료를 위한 3-아세틸아미노-1-(페닐-헤테로아릴-아미노카르보닐 또는 페닐-헤테로아릴-카르보닐아미노)벤젠 유도체 | |
| BR112021004599A2 (pt) | inibição de peptidase 9x específica de ubiquitina | |
| TW201211010A (en) | Novel heterocyclic derivative and pharmaceutical composition comprising the same | |
| ES2936481T3 (es) | 1H-Indazol-carboxamidas como inhibidores de la proteína cinasa 1 que interactúa con el receptor (RIPK1) | |
| TWI748142B (zh) | 抗腫瘤劑 | |
| UA80184C2 (en) | Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands | |
| JP7291696B2 (ja) | アルファｖインテグリン阻害剤としてのピロロピラジン誘導体 | |
| CA2943002A1 (en) | Novel compounds | |
| CN106458984A (zh) | 作为大麻素受体激动剂的5，6‑双取代的吡啶‑2‑甲酰胺 | |
| CN109071434A (zh) | 酰基磺酰胺NaV1.7抑制剂 | |
| TW200823195A (en) | Substituted oxindole derivatives, medicinal products containing them, and use thereof | |
| CN112745298A (zh) | 多取代异吲哚啉类化合物、其制备方法、药物组合物及用途 | |
| CA3172589A1 (en) | Piperidine-2,6-diones as small molecule degraders of helios and methods of use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
| B06W | Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2798 DE 20/08/2024. |